Research programme: metformin/atypical antipsychotic - BTGAlternative Names: Metformin/atypical antipsychotic
Latest Information Update: 16 Jul 2016
At a glance
- Originator BTG
- Class Biguanides
- Mechanism of Action Dopamine D2 receptor antagonists; Serotonin 2 receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Obesity
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Obesity(Combination therapy) in United Kingdom (PO)
- 01 Jun 2007 Preclinical trials in Obesity in United Kingdom (PO)